SCHEMBL30709362

SCHEMBL30709362

Cc1ccc2c(c1)c1cc(C)ccc1n2-c1nc(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-n2c3ccc(C)cc3c3cc(C)ccc32)c(-c2ccccc2-c2cc(C)nc(C)c2)c1-n1c2ccc(C)cc2c2cc(C)ccc21

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGDR2 Q9Y5Y4 1/20 0.35
MEN1 O00255 2/20 0.34
KMT2A Q03164 2/20 0.34
NR1I2 O75469 1/20 0.34
AHR P35869 1/20 0.34
KDM4E B2RXH2 2/20 0.32
MAPT P10636 2/20 0.32
NPSR1 Q6W5P4 2/20 0.32
APAF1 O14727 1/20 0.32
PKM P14618 1/20 0.32
IDO1 P14902 1/20 0.32
MAPK1 P28482 1/20 0.32
HTT P42858 1/20 0.32
RAB9A P51151 1/20 0.32
MCL1 Q07820 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
NLRP3 Q96P20 1/20 0.31
LMNA P02545 3/20 0.30
ALDH1A1 P00352 1/20 0.30
RECQL P46063 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22126317 1.00 PTGDR2 (0.35) PTGDR2MEN1KMT2ANR1I2AHR
SCHEMBL30709558 0.96 PTGDR2 (0.35) PTGDR2MEN1KMT2ANR1I2AHR
SCHEMBL30709287 0.86 MEN1 (0.45) MEN1KMT2ANR1I2AHRKDM4E
SCHEMBL30709496 0.85 PTGER4 (0.33) KDM4ETDP1ALDH1A1
SCHEMBL30709450 0.84 MAPT (0.30) MAPT
SCHEMBL30709611 0.84 DNMT1 (0.32) MEN1KMT2AKDM4EMAPTNPSR1
SCHEMBL30709213 0.83 MEN1 (0.43) MEN1KMT2ANR1I2AHRKDM4E
SCHEMBL30709386 0.83 L3MBTL1 (0.36) MEN1KMT2ANR1I2AHRKDM4E
SCHEMBL30709344 0.83 TGFBR1 (0.37) MEN1KMT2ANR1I2AHR
SCHEMBL30709418 0.82 PTGER4 (0.37) KDM4EMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11849634-B2 Composition of matter for use in organic light- emitting diodes KYULUX, INC. (JP) 2023-12-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11849634-B2 Composition of matter for use in organic light- emitting diodes NDUFV3, NDUFV2, CRY2 PTGDR2 1959/4885MEN1 2193/4885KMT2A 4367/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.